日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

T follicular helper cells transiently unlock a plasticity state in germinal centre B cells during the humoral immune response.

在体液免疫反应过程中,滤泡辅助性T细胞可短暂地激活生发中心B细胞的可塑性状态。

Scourzic Laurianne, Izzo Franco, Teater Matt, Polyzos Alexander P, Cucereavii Lucretia, Chin Christopher R, Papin Antonin, Pinto Hugo B, Mlynarczyk Coraline, Tsialta Ioanna, Xia Min, Lidoski Abigail, Myers Robert M, Israel Eva M, Venturutti Leandro, Mackay Simon P, Hoehn Kenneth B, Skoultchi Arthur I, Béguelin Wendy, Stadtfeld Matthias, Chen Zhengming, Landau Dan A, Melnick Ari M, Apostolou Effie

Biofeedback Impact on Limb Stiffness and Joint Power in Patients With ACL Reconstruction-A Secondary Analysis

生物反馈对前交叉韧带重建患者肢体僵硬和关节力量的影响——一项二次分析

Rathod, Vaibhavi; Vasquez, Bryana N; Teater, Michael A; Arena, Sara L; Queen, Robin M

EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function

EZH2抑制通过诱导淋巴瘤免疫原性和改善T细胞功能来增强T细胞免疫疗法。

Yusuke Isshiki,Xi Chen,Matt Teater,Ioannis Karagiannidis,Henna Nam,Winson Cai,Cem Meydan,Min Xia,Hao Shen,Johana Gutierrez,Vigneshwari Easwar Kumar,Sebastián E Carrasco,Madhu M Ouseph,Samuel Yamshon,Peter Martin,Ofir Griess,Efrat Shema,Patrizia Porazzi,Marco Ruella,Renier J Brentjens,Giorgio Inghirami,Roberta Zappasodi,Amy Chadburn,Ari M Melnick,Wendy Béguelin  0

EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function

EZH2抑制通过诱导淋巴瘤免疫原性和改善T细胞功能来增强T细胞免疫疗法。

Yusuke Isshiki ,Xi Chen ,Matt Teater ,Ioannis Karagiannidis ,Henna Nam ,Winson Cai ,Cem Meydan ,Min Xia ,Hao Shen ,Johana Gutierrez ,Vigneshwari Easwar Kumar ,Sebastián E Carrasco ,Madhu M Ouseph ,Samuel Yamshon ,Peter Martin ,Ofir Griess ,Efrat Shema ,Patrizia Porazzi ,Marco Ruella ,Renier J Brentjens ,Giorgio Inghirami ,Roberta Zappasodi ,Amy Chadburn ,Ari M Melnick ,Wendy Béguelin

Effects of the Communities That HEAL intervention on initiation, retention, and linkage to medications for opioid use disorder (MOUD): A cluster randomized wait-list controlled trial

“社区康复”干预措施对阿片类药物使用障碍(MOUD)患者的启动、维持和药物治疗衔接的影响:一项整群随机等待名单对照试验

Brown, Jennifer L; Larochelle, Marc R; Fanucchi, Laura C; Calvert, Deirdre C; Campbell, Aimee N C; Chandler, Redonna K; Feaster, Daniel J; Glasgow, LaShawn M; Gibson, Erin B; Holloway, JaNae; Lofwall, Michelle R; Mack, Aimee; Mack, Nicole; Nunes, Edward V; Talbert, Jeffery C; Tan, Sylvia; Vandergrift, Nathan; Villani, Jennifer; Asman, Kat; Babakhanlou-Chase, Hermik; Bagley, Sarah M; Battaglia, Tracy A; Blevins, Derek; Bridden, Carly; Cheng, Debbie M; Christopher, Mia; Cogan, Lindsay W; Cunningham, Chinazo O; Eggleston, Barry; Fareed, Naleef; Fernandez, Soledad; Freedman, Darcy A; Freiermuth, Caroline E; Freisthler, Bridget; Gilbert, Louisa; Hammerslag, Lindsey; Harris, Daniel; Hunt, Timothy; Hussain, Shazia; Huynh, Phuong; Jackson, Rebecca D; Kauffman, Emily B; Knott, Charles; Knudsen, Hannah K; Lefebvre, R Craig; Levin, Frances R; Massatti, Rick; McAlearney, Ann Scheck; Morgan, Jake R; Lopez, Rosie Munoz; Lounsbury, David W; Newman, Lisa; Nickels, Katrina; Oga, Emmanuel A; Oller, Devin A; Parran, Theodore V; Quinn, Maria; Ramsey, Kelly S; Rapkin, Bruce D; Salsberry, Pamela; Stein, Michael; Taylor, Jessica L; Teater, Julie; Walters, Scott T; Zarkin, Gary A; El-Bassel, Nabila; Winhusen, T John; Samet, Jeffrey H; Walsh, Sharon L

Perspectives on ageing acceptance among women in middle adulthood: a qualitative study

中年女性对衰老接受度的看法:一项定性研究

Gegieckaitė, Goda; Rapolienė, Gražina; Kukulskienė, Milda; Chonody, Jill; Teater, Barbra

The STop UNhealthy substance use now (STUN II) trial: protocol for a 48-site cluster randomized 2 × 2 factorial implementation trial to improve evidence-based screening and interventions for substance use disorder within primary care

立即停止不健康物质使用(STUN II)试验:一项包含48个研究中心的整群随机2×2析因设计实施试验方案,旨在改进初级保健中基于循证医学的物质使用障碍筛查和干预措施。

Jonas, Daniel E; Brill, Seuli Bose; Fried, Martin; Brouwer, Leslie; Riley, Sean; MacEwan, Sarah R; Hyer, Madison; Palettas, Marilly; Hall, Orman Trent; Vilensky, Michael; Teater, Julie; Carson, William Felkel 2nd; Wei, Lai; Garner, Bryan R

SMARCA4 is a haploinsufficient B cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate decisions

SMARCA4 是一种单倍体不足的 B 细胞淋巴瘤抑癌基因,它精细调控中心细胞的命运决定。

Qing Deng,Priya Lakra,Panhong Gou,Haopeng Yang,Cem Meydan,Matthew Teater,Christopher Chin,Wenchao Zhang,Tommy Dinh,Usama Hussein,Xubin Li,Estela Rojas,Weiguang Liu,Patrick K Reville,Atish Kizhakeyil,Darko Barisic,Sydney Parsons,Ashley Wilson,Jared Henderson,Brooks Scull,Channabasavaiah Gurumurthy,Francisco Vega,Amy Chadburn,Branko Cuglievan,Nader Kim El-Mallawany,Carl Allen,Christopher Mason,Ari Melnick,Michael R Green

ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesis

ARID1A 协调 SWI/SNF 介导的转录因子顺序结合,ARID1A 缺失驱动前记忆 B 细胞命运和淋巴瘤发生。

Darko Barisic,Christopher R Chin,Cem Meydan,Matt Teater,Ioanna Tsialta,Coraline Mlynarczyk,Amy Chadburn,Xuehai Wang,Margot Sarkozy,Min Xia,Sandra E Carson,Santo Raggiri,Sonia Debek,Benedikt Pelzer,Ceyda Durmaz,Qing Deng,Priya Lakra,Martin Rivas,Christian Steidl,David W Scott,Andrew P Weng,Christopher E Mason,Michael R Green,Ari Melnick

SMARCA4 is a haploinsufficient B cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate decisions

SMARCA4 是一种单倍体不足的 B 细胞淋巴瘤抑癌基因,它精细调控中心细胞的命运决定。

Qing Deng ,Priya Lakra ,Panhong Gou ,Haopeng Yang ,Cem Meydan ,Matthew Teater ,Christopher Chin ,Wenchao Zhang ,Tommy Dinh ,Usama Hussein ,Xubin Li ,Estela Rojas ,Weiguang Liu ,Patrick K Reville ,Atish Kizhakeyil ,Darko Barisic ,Sydney Parsons ,Ashley Wilson ,Jared Henderson ,Brooks Scull ,Channabasavaiah Gurumurthy ,Francisco Vega ,Amy Chadburn ,Branko Cuglievan ,Nader Kim El-Mallawany ,Carl Allen ,Christopher Mason ,Ari Melnick ,Michael R Green